Loading clinical trials...
Loading clinical trials...
This is a 60 week study including a double-blind phase followed by an open-label extension phase.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Allergan
NCT04715685 · Headache, Headache Disorders, and more
NCT07170176 · Migraine Disorders, Patent Foramen Ovale, and more
NCT05570149 · Migraine Disorders
NCT05690737 · Migraine Disorders
NCT06485726 · Migraine Disorders
Seattle, Washington
Markham, Ontario
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions